WHO Asks Vietnam to Assist in Creating Vaccine Against Human Bird Flu Virus
Posted on: Thursday, 8 December 2005, 09:00 CST
Text of report in English by Vietnamese news agency VNA website
Hanoi, 7 December: The World Health Organization has asked Vietnamese scientists from the Central Hygiene and Epidemiology Institute (CHEI) to cooperate in creating a vaccine against the H5N1 virus for humans.
The request reflects the WHO's recognition of Vietnamese scientists' capability, as they have in a short period developed six different types of H5N1 vaccines which have met the WHO's minimal required protocols.
These vaccines have been successfully tested on mice, chickens and monkeys and their samples have been sent to WHO's labs for re- examination.
While awaiting the results from WHO's labs, Vietnamese developers of H5N1 vaccine have submitted a request to authorized agencies for permission to conduct human testing for their products.
According to Prof Nguyen Thi Thu Van, a member of the vaccine research group, human testing will be carried out in two phases.
In the first phase, the vaccine would be tested on around 20-30 people, mainly on vaccine developers, to examine its safety.
In the second phase, the testing would be conducted on 200-300 people to recheck the vaccine's safety and its immunity, said Prof Van, who is director of the Vaccines and Bioproducts Company No.1.
If the human testing for the vaccine is successful, the Vietnamese-made H5N1 vaccine for humans could be ready for mass- production four months later, at a cost of around 30,000 VND (roughly 1.9 US dollars) per dose.
Scientists from CHEI started developing H5N1 vaccines in late 2004, when bird flu re-emerged in Vietnam and other countries.
Scientists have used cell culture technology, which involves taking a seed virus from deactivated or weakened form of the virus from a bird flu victim. The sample is then grown in monkey kidney cells.
Avian influenza has claimed 42 lives in Vietnam since it first hit the country late 2003.
Source: BBC Monitoring Asia Pacific
Related Articles
- Medicago's H5N1 VLP Vaccine Provides Protection Against Multiple Strains of Avian Flu
- Sinovac Commences Phase II Clinical Trials for Pandemic Influenza Vaccine (H5N1)
- Baxter Announces Safety and Immunogenicity Results From Phase I/II Clinical Trial of Cell-Based Candidate H5N1 Pandemic Vaccine
- Independent Forensics Releases First Test to Measure Human Genetic Resistance to HIV
- Sinovac Completes Immunization Schedule in the Phase I Clinical Trial of Its Proprietary Avian Influenza Vaccine (H5N1)
- Australian Scientists Test Nipah Virus Vaccine
- Canadian Company to Produce H5N1 Flu Vaccine
- Federal Government, Vaccine Maker Finally Sign Deal to Make H5N1 Flu Vaccine
- China's Self-Made Human Avian Influenza Vaccine Ready for Clinical Test
- A Success in Search for Avian Flu Vaccine Test Seen Protecting Humans From Virus Spreading in Asia
 |
 |
User Comments (0)
RSS Feeds